Sarepta Therapeutics (SRPT) Earnings Date, Estimates & Call Transcripts $49.16 -0.14 (-0.28%) As of 09:37 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Sarepta Therapeutics Earnings Summary Upcoming Q2 2024 Earnings DateApr. 29After Market ClosesEstimatedConsensus EPS (Aug. 7) $0.01 Actual EPS (Aug. 7) $0.07 Beat By $0.06 Actual Revenue (Aug. 7) $362.90MSarepta Therapeutics announced Q2 2024 earnings on August 7, 2024, reporting an EPS of $0.07, which topped analysts' consensus estimates of $0.01 by $0.06. Quarterly revenue rose 38.9% year-over-year to $362.90 million, below the consensus estimate of $394.38 million. With a trailing EPS of $2.28 and a P/E Ratio of 39.62, Sarepta Therapeutics' earnings are expected to grow 309.74% next year, from $2.67 to $10.94 per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)SRPT Upcoming EarningsSarepta Therapeutics' Q1 2025 earnings is scheduled for Tuesday, April 29, 2025, with a conference call scheduled on Wednesday, April 30, 2025 at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Sarepta Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sarepta Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSRPT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SRPT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Sarepta Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253$1.89$2.45$2.08Q2 20253$1.99$2.69$2.44Q3 20253$2.61$2.81$2.73Q4 20253$2.85$3.60$3.11FY 202512$9.34$11.55$10.37Q1 20261$3.06$3.06$3.06Q2 20261$3.58$3.58$3.58Q3 20261$3.56$3.56$3.56Q4 20261$3.60$3.60$3.60FY 20264$13.80$13.80$13.80Q1 20271$2.90$2.90$2.90 Remove Ads Sarepta Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 4/29/2025(Estimated)--------8/7/2024Q2 2024$0.01$0.07+$0.06$0.07$394.38M$362.90M5/1/2024Q1 2024-$0.11$0.73+$0.84$0.39$375.52M$413.50M2/28/2024Q4 2023-$0.03$0.47+$0.50$0.47$387.18M$396.80M11/1/2023Q3 2023-$1.63$0.37+$2.00-$0.46$285.33M$331.80M8/2/2023Q2 2023-$1.89-$0.27+$1.62-$0.27$255.99M$261.20M5/2/2023Q1 2023-$1.46-$0.97+$0.49$2.98$241.47M$253.50M Sarepta Therapeutics Earnings - Frequently Asked Questions When is Sarepta Therapeutics's earnings date? Sarepta Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 29th, 2025 based off last year's report dates. Learn more on SRPT's earnings history. Did Sarepta Therapeutics beat their earnings estimates last quarter? In the previous quarter, Sarepta Therapeutics (NASDAQ:SRPT) reported $0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.06. Learn more on analysts' earnings estimate vs. SRPT's actual earnings. How can I listen to Sarepta Therapeutics's earnings conference call? The conference call for Sarepta Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Sarepta Therapeutics's conference call transcript? The conference call transcript for Sarepta Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Sarepta Therapeutics generate each year? Sarepta Therapeutics (NASDAQ:SRPT) has a recorded annual revenue of $1.90 billion. How much profit does Sarepta Therapeutics generate each year? Sarepta Therapeutics (NASDAQ:SRPT) has a recorded net income of -$535.98 million. SRPT has generated $2.28 earnings per share over the last four quarters. What is Sarepta Therapeutics's price-to-earnings ratio? Sarepta Therapeutics (NASDAQ:SRPT) has a trailing price-to-earnings ratio of 39.44 and a forward price-to-earnings ratio of 18.46. What is Sarepta Therapeutics's EPS forecast for next year? Sarepta Therapeutics's earnings are expected to grow from $2.67 per share to $10.94 per share in the next year, which is a 309.74% increase. More Earnings Resources from MarketBeat Related Companies TEVA Earnings Date ITCI Earnings Date SMMT Earnings Date GMAB Earnings Date RDY Earnings Date MRNA Earnings Date VTRS Earnings Date QGEN Earnings Date ASND Earnings Date ROIV Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go Higher Remove Ads This page (NASDAQ:SRPT) was last updated on 4/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Silver isn't just a safe haven for your wealth—it's a critical resource in the global tech and energy race. Wi...GoldenCrest Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sarepta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sarepta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SRPT Stock Free SRPT Stock Alerts